Addressing Immune System Insufficiencies
Renovion, Inc. is a clinical stage pharmaceutical company headquartered out of Chapel Hill, North Carolina. Renovion has created a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. The company is focused on developing ARINA-1 for orphan chronic inflammatory lung diseases. The company has secured an SBIR Direct-to-Phase 2 grant to fund a Phase 2/3 NDA-enabling clinical trial in lung transplant!